During the quarter, Cell Impact continued to deepen the cooperation with F.C.C. which after the end of the quarter led to two formal agreements. The first is a formal extension of the current cooperation agreement in the form of a leasing agreement and the other is a framework agreement that regulates the conditions for continued cooperation between the companies.

In March, the company announced its first deal in the area of electrolysis. The agreement extends over 30 months and was signed with a new European customer. It includes an initial delivery of flow plates, tooling and fixtures worth just over SEK 18 million.

One proof that customers need the company's expertise and offerings is evident in the large number of concrete test tools being requested. We are seeing great interest from existing, new and prospective customers in the production lines which among other things include forming, high-precision punching and laser welding.

"The great interest gives me great confidence in the company's future development. Our secured financing for 2024 and into 2025 gives us the platform we need to translate some of these projects into new revenues, " said Daniel Vallin, interim CEO of Cell Impact.

• Net sales totaled SEK 5.8 million (20.0).
• Operating loss (EBIT) was SEK -22.0 million (-29.9).
• The Group's result after financial items was SEK -22.8 million (-30.5).
• Earnings per share attributable to the Parent Company's shareholders before and after dilution totaled SEK -0.04 (-0.40).
• Debt/equity ratio was 81 percent (79) on the balance sheet date.
• Cash flows from operating activities amounted to SEK -43.2 million (-29.6).
• On the balance sheet date, the Group's cash and cash equivalents totaled SEK 47.6 million (117.7).

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.